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One of the most common hereditary craniofacial anomalies in humans are cleft lip and
cleft alveolar bone with or without cleft palate. Current clinical practice, the augmentation
of the persisting alveolar bone defect by using autologous bone grafts, has considerable
disadvantages motivating to an intensive search for alternatives. We developed a novel
therapy concept based on 3D printing of biodegradable calcium phosphate-based
materials and integration of osteogenic cells allowing fabrication of patient-specific,
tissue-engineered bone grafts. Objective of the present study was the in vivo evaluation
of implants in a rat alveolar cleft model. Scaffolds were designed according to the
defect’s geometry with two different pore designs (60◦ and 30◦ rotated layer orientation)
and produced by extrusion-based 3D plotting of a pasty calcium phosphate cement.
The scaffolds filled into the artificial bone defect in the palate of adult Lewis rats, showing
a good support. Half of the scaffolds were colonized with rat mesenchymal stromal cells
(rMSC) prior to implantation. After 6 and 12 weeks, remaining defect width and bone
formation were quantified histologically and by microCT. The results revealed excellent
osteoconductive properties of the scaffolds, a significant influence of the pore geometry
(60◦ > 30◦), but no enhanced defect healing by pre-colonization with rMSC.
Keywords: 3D printing, bone graft, bone tissue engineering, alveolar cleft model, calcium phosphate cement
INTRODUCTION
During embryologic development of the craniomaxillofacial anatomy, tissue fusion is essential.
In cases of non- or incomplete fusion, soft and/or hard tissue defects will remain after birth.
The most common examples for congenital craniofacial anomalies caused by an incomplete
tissue fusion are cleft lip and cleft alveolus with or without a cleft palate. The prevalence
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in humans varies between different ethnical groups and averaged
for Caucasians at one per 700 live births (Dixon et al.,
2011). Three of four cleft lip and palate patients expose an
alveolar osseous defect (Guo et al., 2011). Children suffering
from a complete cleft palate, alveolus and lip require an
extensive treatment from their first months until adolescence.
One aspect of the surgical therapy is the augmentation of the
persisting alveolar bone defect, called alveolar cleft osteoplasty,
by autologous bone grafts. This has to be performed at the age
of 9–11 years in order to create sufficient bone volume, allowing
the eruption of the permanent canine. Additionally, bone grafting
of this defect normalizes facial and dental function. Failure
to reconstruct this osseous deformity may result in oronasal
fistula, fluid reflux, speech pathology, anteroposterior deficiency
of the maxilla, transverse deficiency of the maxilla, lack of bone
support for the teeth, dental crowding, and facial asymmetry
(Waite and Waite, 1996).
Up to now, the alveolar cleft osteoplasty uses mainly
autologous bone grafts from the iliac crest, providing osteogenic,
osteoinductive and osteoconductive properties (Lopez et al.,
2018). A disadvantage of these bone grafts is the need of
harvesting with associated donor site morbidity. In cases of
maxillofacial and cleft reconstructions, the following rates of
complications in the donor site region are summarized by
a review of Boehm et al. (2018): acute (45.7%) and chronic
(1.5%) gait disturbance, acute (17.8%) and chronic nerve
changes (1.4%), hypertrophic/painful scar (9.1%), chronic pain
(3.1%), hematoma (2.2%), seroma (2.0%), infection (1.0%)
and iliac crest fracture (1.2%). Against this background, it is
of great clinical interest to evaluate biomaterials regarding
their potential to be an alternative for the autologous
bone grafts. For small oral bone defects alloplastic and
xenogenic materials are well established, but for congenital
and critical size defects the clinical results of these materials
are currently not sufficient (Feinberg et al., 1989). Hence,
there are great efforts to develop bone grafts, which can be
used for the reconstruction of critical size defects like alveolar
clefts (Silva Gomes Ferreira et al., 2018). The bone grafts
should have the following characteristics: osteoconductivity,
mechanical stability, promotion of vascular ingrowth and
stem cell recruitment, and progressive resorption during
the replacement by native tissue (Hutmacher et al., 2007;
Kim et al., 2017).
Ideally, the bone graft is patient-specific and fits exactly into
the defect area. This can be achieved by additive manufacturing
of an implant based on a 3D model that is designed by using
computer tomography (CT) or magnet resonance tomography
(MRT) data of the defect region (Pfister et al., 2004). In the
last two decades, various methods of additive manufacturing
have been adapted to the fabrication of medical implants and
tissue engineering constructs, amongst them extrusion-based
fabrication methods (Landers et al., 2002; Malda et al., 2013).
Extrusion printing in mild conditions, for example by avoidance
of unphysiological temperatures, pH or energy-intensive post-
printing treatment, is called 3D plotting (Moroni et al., 2018).
The mild processing conditions allow the combined processing
of materials and biological substances like proteins/growth
factors and cells (called bioplotting) (Fedorovich et al., 2008;
Poldervaart et al., 2013).
The regeneration of tissue defects is accomplished by cells;
the biomaterial just fills the defect volume and provides a
supporting substrate by mimicking the extracellular matrix. The
cells invade into the defect region from the surrounding tissue or
the biomaterial scaffold is pre-colonized with regenerative cells
according to the tissue engineering concept; growth factors and
other signaling molecules can be integrated in the material to
stimulate cellular reactions necessary for tissue regeneration such
as migration, proliferation and differentiation (Hutmacher et al.,
2007). Previous preclinical studies investigated tissue engineering
approaches in the context of alveolar cleft osteoplasty by testing
calcium phosphate-based biomaterials which were pre-colonized
with rat mesenchymal stromal cells (rMSC) (Korn et al., 2014,
2017) or coated with bone morphogenetic protein 2 (BMP-2)
(Nguyen et al., 2009) in rat alveolar cleft models. The mentioned
material combinations showed local bone formation within the
artificial defect, but no complete osseous defect healing. First
trials of clinical application of tissue engineered bone grafts led
to promising results. An example is the study of Pradel and Lauer
(2012), who found comparable rates of bone formation for pure
autologous (from iliac crest) and mixed alloplastic (autologous
osteoblasts obtained from maxilla bone biopsies and cultured
on demineralized bone matrix Osteovit bone grafts). Guo et al.
(2011) reported for collagen bone graft substitutes impregnated
with BMP-2 (InFuse bone graft, Sofamor-Danek, United States)
comparable results. However, most studies have in common, that
the small number of patients might led to a high bias of the
results and up to now no real alternative bone graft is clinically
established (Liang et al., 2018).
We aim to develop a novel concept for the treatment of
alveolar cleft patients by the combination of 3D plotting
of patient-specific bone implants and tissue engineering
approaches; due to their resemblance of the natural bone
mineral, we focus on calcium phosphate-based materials. Herein,
we utilized a plottable, clinically approved calcium phosphate
cement paste (CPC), which is composed of calcium phosphate
precursors (mainly α-tricalcium phosphate) and a biocompatible,
but hydrophobic (oil-based) carrier liquid (Heinemann et al.,
2013; Lode et al., 2018). This composition allows long storage
and unlimited extrusion in mild conditions (Lode et al., 2014).
Macroporous CPC scaffolds can be plotted with high accuracy,
afterward the scaffolds need to be hardened in an aqueous
environment (Akkineni et al., 2015; Ahlfeld et al., 2017). During
this setting procedure, the carrier liquid vanishes from the
scaffold structure without residues and the precursors set to
nanocrystalline calcium-deficient, carbonated hydroxyapatite,
which can be resorbed by osteoclasts (Bernhardt et al., 2014;
Reitmaier et al., 2018). The mechanical properties of bulk and
plotted CPC samples were characterized thoroughly in the
past (Ahlfeld et al., 2017; Lode et al., 2018). Patient-specific
scaffold structures can be fabricated by 3D plotting of CPC
(Ahlfeld et al., 2018b).
In the present study, we analyzed custom-made bone grafts
consisting of 3D plotted CPC scaffolds and rMSC in a small
animal model of cleft alveolar osteoplasty. The hypothesis of the
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study was “The application of a 3D plotted bone graft into an
artificial maxillary bone defect leads to a significant reduction
of the defect width after 12 weeks.” To better understand
the performance of 3D plotted implants, we investigated the
influence of the fabricated pore geometry on bone formation in
the defect area, as well as the effect of rMSC seeded onto the
scaffold prior to implantation.
MATERIALS AND METHODS
3D Plotting of CPC Scaffolds
The plottable CPC paste (INNOTERE Paste-CPC), manufactured
by INNOTERE GmbH (Radebeul, Germany), was sterilized by
γ-irradiation (25 kGy) and transferred into cartridges (Nordson
EFD, Oberhaching, Germany) which were placed into a three-
axis robotic dispensing system (Bioscaffolder 3.1, GeSiM mbH,
Radeberg, Germany). For the in vitro and in vivo study, scaffolds
with a diameter of 3.0 and 3.2 mm and a height of 0.48 mm (four
layers) were plotted utilizing a 230 µm needle (Globaco GmbH,
Rödermark, Germany) with a plotting speed of 10 mm·s−1 and
an air pressure of 150 kPa. Inner geometry of the scaffolds was
adjusted as follows: strand-to-strand distance 0.5 mm, layer-
to-layer orientation 60◦ (Scaffold A) or 30◦ (Scaffold B). After
plotting, scaffolds were incubated for 3 days in water-saturated
atmosphere (humidity > 95%, temperature 37.4◦C) (Akkineni
et al., 2015), followed by three intensive washing steps in
acetone to remove residual oil of the CPC paste. The whole
fabrication process was conducted under sterile conditions.
Scaffolds were immersed in cell culture medium consisting of
alpha-MEM (Gibco, Thermo Fisher Scientific GmbH, Germany)
with 10% fetal calf serum (FCS), 100 Uml−1 penicillin and
100 mgml−1 streptomycin (Pen/Strep, all from Biochrom, Berlin,
Germany) 24 h prior to subsequent cell seeding. The anatomical
model was virtually segmented, modified and constructed with
the softwares Dornheim segmenter (Dornheim Medical Images
GmbH, Magdeburg, Germany), Geomagic Studio (RSI 3D-
Systems, Oberursel, Germany) and Geomagic Freeform (RSI
3D-Systems, Oberursel, Germany). As sacrificial ink a 10%
methylcellulose (mc, M0512, Sigma, United States, molecular
weight ≈88000 Da, 4000 cP) paste was prepared in water as
described before (Ahlfeld et al., 2018b). The sacrificial ink was
plotted utilizing a 410 µm needle with a speed of 10 mm·s−1;
after post-processing, it was washed away in the fridge overnight.
Seeding of the Scaffolds With rMSC for
in vitro and in vivo Experiments
rMSC were isolated from the bone marrow of adult Lewis
rats as described previously (Korn et al., 2017). In brief, bone
marrow was aspirated from the femur, centrifuged for 10 min at
1200 rpm and the pellet was resuspended in cell culture medium
consisting of alpha-MEM with 10% fetal calf serum, Pen/Strep,
1% Amphotericin and 1 M HEPES buffer solution (all from
Gibco, Thermo Fisher). The cell suspension was transferred into
culture flasks; the medium was changed every 3–4 days and the
cells were expanded until the second passage. For cell seeding,
the immersed scaffolds were placed into 0.2 ml PP multiply-pro
cups (Sarstedt; one scaffold per tube) and 280 µl cell suspension
containing either 1 × 105 cells (for the in vitro experiments)
or 2 × 105 cells (for the in vivo experiments) were added. The
scaffold colonization was performed by a rotation method: during
a period of 6 h, the tubes were rotated every 30 min one and
a half turn while they were stored in the incubator at 37◦C
and 5% CO2. Finally, the scaffolds were placed in 96-well plates
which were filled with cell culture medium. For the in vivo
experiments, the bone grafts stayed in the incubator at 37◦C,
5% CO2 and 95% humidity for 3 days until implantation. The
scaffolds which were not colonized with cells were treated with
the same procedure to ensure same conditions for the material
prior to implantation.
In vitro Experiment
Seeded scaffolds were cultivated in cell culture medium at 37◦C,
5% CO2 and 95% humidity for 28 days; for half of the samples
osteogenic supplements (10−7 M dexamethasone, 0.05 mM
ascorbic acid 2-phosphate, 10 mM beta-glycerophosphate; all
from Sigma-Aldrich) were added to the medium starting
1 day after seeding. For fluorescence microscopic analyses,
cell-colonized scaffolds were fixed using 4% formaldehyde and
actin cytoskeletons and cell nuclei were stained with AlexaFluor
488 R© phalloidin (Invitrogen) and DAPI (Sigma-Aldrich); imaging
was performed with a Keyence BZ9000E. For biochemical
analysis of LDH and ALP activity, the samples, frozen at
different time points of cell culture, were thawed and incubated
with lysis buffer (1% Triton X-100 in PBS) for 50 min on
ice; cell lysis was supported by sonication for 10 min. LDH
activity in the lysates was determined with the CytoTox 96
Non-radioactive Cytotoxicity Assay (Promega) according to the
manufacturer’s instruction and correlated with the cell number
using a calibration line. Measurement of ALP activity was done
as described previously (Lode et al., 2014). In brief, an aliquot of
the lysate was incubated with 1 mg ml−1p-nitrophenylphosphate
(Sigma-Aldrich) in ALP substrate buffer (0.1 M diethanolamine,
1% Triton X-100, 1 mM MgCl2, pH 9.8) at 37◦C for 30 min.
The enzymatic reaction was stopped by addition of 1 M NaOH
and the p-nitrophenolate (pNp) formation was quantified by
measurement of the absorbance at 405 nm. Using a p-nitrophenol
calibration line, the amount of pNp produced by the cell lysate
was calculated and related to the cell number in each sample
(calculated from the LDH activity).
In vivo Application in a Rat Alveolar Cleft
Model
The animal study was approved by the Commission for Animal
Studies at the District Government Dresden, Germany (DD24-
5131/354/26). For the study, 80 adult male Lewis rats (Janvier
Labs, Le Genest-Saint-Isle, France) with an average body weight
of 450 g and an age of 6 months at the beginning were used. All
animals were housed according to the current regulations in a
light- and temperature-controlled environment. They had access
to water ad libitum and were fed with pellets (ssniff-Spezialdiäten
GmbH, Soest, Germany). After statistical calculation of the
required number of animals per group all rats were randomly
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divided into the 5 experimental groups (see Table 1). The
rats were anesthetized by intraperitoneal injection of ketamine
(100 mg/kg body weight) and xylazine (10 mg/kg body weight)
and fixed in a dorsal position. An artificial alveolar cleft was
created surgically in the anterior maxilla of each animal. First,
a sagittal incision was made following the mid-palatal suture.
After elevation of a mucosal flap and removal of the periosteum,
a localized bone defect with 3.3 mm in diameter was created
using a diamond-coated cylindrical shaped drill (DiT Dental-
Instrumente GmbH, Oberlungwitz, Germany). According to
the randomized distribution, each rat received one bone graft
(Table 1). After insertion of the bone graft, the flap was
repositioned and wound closure was performed using 5-0 Ethilon
suture (Ethicon, Norderstedt, Germany). Postoperatively, the
animals received amoxicillin trihydrate (Fort Dodge Veterinär
GmbH, Würselen, Germany) 15 mg/kg body weight once and
4 mg/kg body weight carprofen (Rimadyl;Pfizer Deutschland
GmbH) every 24 h for 4 days. All drugs were injected
subcutaneously. The animals were fed with a soft diet for the first
3 days and, subsequently, received a regular diet. Postoperatively,
the animals and their behavior were monitored and the body
weight was measured every 2 weeks. For the ex vivo assessment
of the dynamic bone formation, all rats received intraperitoneal
injections of the fluorochrome dyes alizarine (20 mg/kg body
weight) and calcein (30 mg/kg body weight) 7 and 3 days
prior to sacrifice.
Evaluation Methods
After sacrifice, the cranium of each rat was dissected and fixed in
4% formaldehyde. MicroCT and preparation of the histological
samples followed.
MicroCT
One 2D-microCT per rat was performed ex vivo using a
VivaCT (SCANCO Medical AG, Brüttisellen, Switzerland) with
the following adjustments: x-ray energy 70kVp and 114 mA,
integration time 200 ms, voxel size 30 µm and conebeam
continuous rotation. A 3D reconstruction of the defect area by
Software Script (SCANCO) followed. The fitting accuracy of the
scaffolds were characterized descriptively.
TABLE 1 | Experimental groups investigated in vivo.
Number of
animals
Bone graft Description Healing time
[weeks]
8 Scaffold A 60◦ layer rotation 6
8 Scaffold A 12
8 Scaffold A + rMSC 6
8 Scaffold A + rMSC 12
8 Scaffold B 30◦ layer rotation 6
8 Scaffold B 12
8 Scaffold B + rMSC 6
8 Scaffold B + rMSC 12
8 Control Empty defect 6
8 Control 12
Histology
After dehydration in a graded series of ethanol, all samples
were embedded in methylmethacrylate (Technovit 9100,
HeraeusKulzer, Wehrheim, Germany) as described previously
(Korn et al., 2014). Coronal sections were produced according
to Donath’s sawing and grinding technique (Donath and
Breuner, 1982). Thus, the four central sections of each specimen
could be achieved for evaluation. Subsequently, the sections
measuring 60 µm in thickness were polished. After analysis of
the fluorochrome marker uptake, Masson-Goldner trichrome
staining followed.
Histological Analysis
All samples were imaged by fluorescence microscopy and,
after staining, by light microscopy (Olympus BX 61, Olympus
Deutschland GmbH, Hamburg, Germany) using cellˆF Imaging
Software for Life Science (Olympus). Multiple image alignment
was performed using an automatic scanning table (Märzhäuser,
Wetzlar, Germany). Thus, 8 images per sample were scanned
with a 10 × 10-fold magnification and manually fused to one
image. Fluorochrome marker uptake was analyzed to assess the
dynamics of bone formation at the defect margins. Focus were
the direction and distribution of the bone formation marked by
the red fluorescent alizarin and the green fluorescent calcein.
Thereafter, all specimens were stained according to Masson-
Goldner trichrome staining. A descriptive analysis evaluated the
position of the scaffold, it’s surface, the interactions between
host bone and bone graft and the bone formation on the defect
margins. Again, a 10 × 10-fold magnification was chosen. For
quantification of the osseous healing the following parameter
were measured: remaining defect width (Equation 1), bone
formation in the defect area, and percentage of the new formed
bone relating to the particular initial defect area (Equation 2). All
measurements were realized by one examiner who was masked
regarding to the experimental groups.
remaining defect width =
distancedefect margins cranial + distancedefect margins caudal
2
(1)
newly formed bone =
new formed bone area
initial osseous defect area
× 100 (2)
Statistics
Results obtained in vitro were checked for statistical significance
by one-way ANOVA coupled with Tukey’s multiple comparison
test utilizing GraphPad Prism version 8 software (GraphPad
Software, La Jolla, CA, United States).
Statistical analysis of the in vivo results were performed with
SPSS 25 software (IBM Germany, Ehningen, Germany) and mean
as well standard deviations were calculated for all groups. The
impact of scaffold and healing time were tested by a two-way-
ANOVA. The interactions between healing time, scaffold and
rMSC colonization could be studied by t-tests with Bonferroni-
adjustment. For all analysis the level of significance was set at
95% (p = 0.05).
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RESULTS
Tissue Engineered, Bioresorbable Bone
Grafts for Artificial Cleft Palates in Lewis
Rats
Tissue Engineering Concept
The tissue engineering concept investigated in this study is
shown in Figure 1. Allogenic mesenchymal stromal cells (rMSC)
were isolated from bone marrow of Lewis rats and expanded
until passage 2. The transfer of allogenic cells causes no
immunological problems, as Lewis rats are an inbreeding breed
of genetically identical animals. Nevertheless, during the later
clinical application, we favored the usage of autologous cells.
Miniaturized, precisely fitting scaffolds consisting of CPC were
plotted in 60◦ (scaffold A) and 30◦ (scaffold B) layer-to-layer
orientation and post-processed by setting in water-saturated
atmosphere (Figures 1, 2A,B). After setting, the strand widths
of the scaffolds A and B were determined as 199.8 ± 9 µm and
195.6 ± 9 µm, respectively. Next, scaffolds were colonized with
the isolated rMSC according to the classical tissue engineering
approach; actin/nuclei stainings of the scaffolds A and B seeded
with rMSC are shown in Figures 2A,B. After a cultivation time
of 3 days, scaffolds were implanted into the Lewis rats. To
investigate the influence of rMSC on healing, cell-free samples
were used as controls. All scaffold types, no matter on layer
orientation or cell population, fitted precisely into the artificial
alveolar cleft (Figure 2C).
In vitro Evaluation
Scaffolds of type A and B were seeded with 1 × 105 rMSC
and cultivated over 28 days in cell culture medium with and
without osteogenic supplements (OS), respectively. At various
time points, cell distribution and density on the scaffolds were
visualized by fluorescence microscopy after staining cell nuclei
and actin cytoskeletons (Figure 3A); the number of cells grown
on the scaffolds was determined by measurement of lactate
dehydrogenase (LDH) activity and osteogenic differentiation
was evaluated by measurement of alkaline phosphatase (ALP)
activity (Figure 3B).
Both, the microscopic analysis and the analysis of LDH
activity as a measure for the number of viable cells indicated
a significant higher initial cell number (day 1) for scaffold A
compared to scaffold B. However, in both cases, a uniform cell
distribution on the scaffolds was achieved by the rotation seeding
method (see Materials and Methods). The seeding efficiency
was approx. 20% in case of scaffold B and nearly 45% in case
of scaffold A. After day 1, the number of cells decreased first
but increased after day 7 when cultured without osteogenic
supplements (OS−); in the presence of osteogenic supplements
(OS+), the decrease of cell number was even stronger, staying
constant during further cultivation (Figure 3B). Nevertheless,
microscopic analyses revealed a complete and uniform coverage
of the CPC strands in all cases (Figure 3A). An increase of the
ALP activity was detected for cells cultivated with osteogenic
supplements (OS+), but not without (OS−), indicating their
differentiation toward the osteoblastic lineage after stimulation;
no significant effect of the pore geometry (scaffold A vs. B) has
been observed (Figure 3B).
In vivo Evaluation
Design of the in vivo Study and Post-operative
Evaluation
Table 1 lists all groups investigated in this study. Scaffolds of type
A and B were implanted either with or w/o cells (seeding cell
number 2 × 105). Healing times were either 6 or 12 weeks. An
empty defect was chosen as control. The study was completed
by 78 of 80 rats, which represents a survival rate of 97.5%. Two
rats died 3 days after surgery due to unknown reason. They
were replaced and finally in all groups 8 rats has been analyzed.
Unfortunately, 2 bone defects of the group Scaffold B + rMSC
after 6 weeks of healing time were prepared too flat, as visible
in the histological sections, and hence were excluded from the
evaluation 74 of 80 scaffolds did not show signs of ruptures due
to mechanical load caused by chewing. Five of the six fractured
scaffolds belong to the group B with the 30◦ strand rotation.
Nevertheless the fractured fragments were not dislocated into
the area outside of the defect. The rats’ body weight at the end
of the study was comparable to the initial weight and all rats
FIGURE 1 | Tissue engineering approach carried out in this study. Rat MSC were isolated from bone marrow of Lewis rats, expanded and seeded onto 3D plotted
CPC scaffolds. After 3 days of cultivation, the tissue engineered bone grafts were implanted. Cell-free scaffolds were used as control.
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FIGURE 2 | Morphology of scaffolds of type A and B, cell colonization and implantation. (A,B) Scheme of the scaffolds, stereomicroscopical images of the scaffolds
after plotting and fluorescence-microscopical images of the scaffolds seeded with rMSC (green: actin cytoskeletons, blue: nuclei, CPC exhibits blue
autofluorescence). Scaffolds of type A were fabricated with 60◦ layer-to-layer orientation and scaffolds of type B with 30◦ layer-to-layer orientation. (C) Empty defect
of the cleft (left) and filled defect with a precisely fitting scaffold (right).
showed an undisturbed behavior. No clinical wound healing
complications were observed.
Microcomputed Tomography Analysis
In µCT images, lamellar and cancellous bone as well as
the scaffolds were isodense. Nevertheless discrimination
between bone and scaffold was possible due to morphological
characteristics. Rarely a fusion of bone and scaffold margin was
visible. The descriptive analysis of the scaffold position, being
performed in axial and coronal sections, showed no differences
between the groups (Figure 4). In some cases, the scaffold was
inserted too far in cranial or caudal direction. Further an angular
scaffold position occurred as well as six scaffolds (5x scaffold B,
1x scaffold A) were fractured at the measurement time point.
Histomorphology: Polyfluorochrome Labeling
For the ex vivo assessment of the dynamic bone formation, all
rats received intraperitoneal injections of the fluorochrome dyes
alizarine and calcein 7 and 3 days prior to sacrifice. All specimens
exposed distinctive green fluorescent calcein labels at both time
points, whereas the red alizarin dye was more pronounced after 6
compared to 12 weeks healing time. In general, two directions
of bone formation occurred: starting from defect margin and
from the nasal septum. The control group showed a homogenous
ossification, which led to cone-like shaped areas of cancellous
bone, beginning on the former defect margin (Figures 5A,B).
After 12 weeks maturation into lamellar bone was observable.
In cases of scaffold insertion, a green auto-fluorescence of the
biomaterial, as well as bone formation toward the scaffold were
visible. After 6 weeks, a bone-to-scaffold contact was detected in
some cases of scaffold A (Figures 5C,D). In this situation, the
labeling was interrupted in the area of contact. Scaffold A+ rMSC
exposed a comparably smaller fluorescence labeling, indicating
a reduced rate of bone formation at the time point of marker
application. The insertion of scaffold B also led to an osteogenesis
starting at the defect margins. Compared to scaffold A the bone-
to-scaffold-contact was rarely visible in scaffold B. Between 6
and 12 weeks, both groups of scaffold B (with and w/o rMSC)
increased bone formation, but to a smaller extent compared to
scaffold A. In cases of suboptimal scaffold position, e.g., angular
position, the bone formation was more pronounced on the defect
site, which was closer to the biomaterial. If the scaffold was
inserted too far into a cranial position, the bone grew underneath.
Histomorphology: Masson-Goldner Trichrome
Staining
All animals showed a healed defect site and no oronasal fistulae
were detected. The discrimination between host bone, which
was dense lamellar bone, and newly formed bone was easily
detectable due to morphological characteristics. Irrespective of
the experimental group, after 6 weeks cone-like shaped cancellous
bone grew into direction of the defect center and also osteoid
structures were detectable at the tip of the cone. With ongoing
healing time, bone maturation occurred, resulting in a more or
less pronounced osseous bridging of the defect. In the control
group the defect was filled with soft tissue and no osseous
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FIGURE 3 | Colonization of the plotted CPC scaffolds with rMSC and osteogenic differentiation in vitro. (A) Stainings of actin cytoskeletons (green) and nuclei (blue)
of rMSC on the scaffold types A and B. CPC revealed a blue autofluorescence. Scale bars represent 300 µm. (B) Cell number analyzed by LDH activity and specific
ALP activity of the rMSC cultured with (OS+) and w/o (OS–) osteogenic supplements (n = 4, mean ± SD, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, # marks the
difference between 30◦ and 60◦ with p < 0.05, n.s., no significance).
FIGURE 4 | Micro-CT after 12 weeks. Exemplary axial sections are shown for
(A) Scaffold A, (B) Scaffold B, and (C) control group.
bridging took place. Groups with the scaffold types A and B
primarily showed a fibrous integration of the defect, however,
on the scaffold surface itself cancellous bone grew toward the
defect center and the biomaterial acted as a guiding structure
(Figure 6A). The shape of the newly formed bone was determined
by the scaffold geometry. During the healing period, cancellous
bone matured into lamellar bone (Figure 6B). In comparison to
cell-free scaffolds of type A, rMSC-colonized scaffolds showed
only negligible differences in bone formation. A bone-to-scaffold-
contact occurred more frequently for the non-enriched scaffold
compared to the scaffold + rMSC. Defects augmented with
scaffold B exposed a smaller amount of newly formed bone
compared to scaffold A, irrespective of rMSC colonization. In
all groups, no resorption of the biomaterial was visible and
no complete osseous healing of the defect was detected. Bone
formation was especially impeded, in case scaffolds and their
pores were covered by a thick layer of fibrous tissue.
Histomorphometry
Remaining defect width [mm]
The remaining defect width decreased in all experimental groups
in comparison to the initial defect’s width and with ongoing
healing time. The reduction of the defect width from 6 to
12 weeks was statistically significant for control and scaffold
A groups (Figure 7A). This parameter showed no statistically
significant differences, comparing all experimental groups.
Bone formation in the defect area [mm2]
Osseous defect healing was detectable in all groups, but the
extent differed (Figure 7B). After 6 weeks, the highest values
were measured for scaffold B + rMSC, followed by the control
group, scaffold A + rMSC, scaffold A and scaffold B; however,
these differences were not significant. After 12 weeks, the results
changed as the control and scaffold A exposed the largest areas
of bone formation – only for this two groups the increase from
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FIGURE 5 | Representative images of polyfluorchrome labeling with alizarin
and calcein in coronal histological sections. (A) Control group after 6 weeks
healing time; 10 × 10 magnification; cone-like shaped bone formation started
from the former defect margins, which led to a partial ossification of the defect
area, but no complete osseous healing. (B) Detail of the defect margin of
image A, 20 × 10 magnification; green calcein labels were followed by red
alizarin labels, showing that cancellous bone grew from the former defect
margin toward the center. (C) Scaffold A group after 6 weeks healing time;
10 × 10 magnification; the scaffold is located in the defect center and
cancellous bone grew on the cranial site of its surface. (D) Detail of the defect
margin of image C, 20 × 10 magnification, newly formed bone with dense
contact to the scaffold. In the contact zone, the labeling is interrupted. (1
lamellar host bone, 2 new formed cancellous bone, 3 alizarin label, 4 calcein
label, 5 scaffold, arrow represents the contact zone between scaffold and
bone).
6 to 12 weeks was statistically significant (control: p = 0.002;
scaffold A p = 0.001). Comparing all groups among each other
after 12 weeks, the following result was found: the control group
showed significantly more bone formation compared to scaffold
A + rMSC (p = 0.028), scaffold B (p = 0.021) and scaffold
B + rMSC (p = 0.031); bone formation in the scaffold A group
was in the same range as those in the control group. Also scaffold
A led to more osseous healing within the defect area compared
to scaffold A + rMSC after 12 weeks (p = 0.048); in case of
scaffold B, no significant differences between the groups with
and without rMSC were observed. These findings were supported
by measurements of the closest distance between scaffold and
ingrowing bone, which was decreasing with ongoing healing time
(Supplementary Figure S1 and Supplementary Table S2).
Percentage of the newly formed bone related to the initial
defect area [%]
If the area of bone formation was calculated against the particular
initial defect area, the values were in accordance to the results
FIGURE 6 | Histomorphology: representative images of Masson-Goldner
trichrome staining in coronal sections. (A) Scaffold A after 6 weeks healing
time; (B) scaffold A after 12 weeks healing time (both 10 × 10 magnification).
There is an ongoing bone formation detectable, whereby the scaffold acts as
a guiding structure for the cancellous bone. The scaffold did not show signs of
resorption at the end of the healing period.
of the bone area (Figure 7C). After 6 weeks, the control group
exposed an osseous defect healing of 13.2% (mean) with a
significant increase to 22.5% at the end of the study. Also scaffold
A showed a significantly increasing bone formation from 8.2
to 19.0%. The other groups had a smaller percentage of bone
formation and no significant differences occurred between 6
and 12 weeks within the groups (Figure 7C). After 12 weeks,
the control group showed significantly higher values of bone
formation compared to scaffold A + rMSC, scaffold B, and
scaffold B + rMSC (all p < 0.001). Also 19.0% of scaffold A
was significantly more than 10.2% of scaffold B (p = 0.02),
10.8 of scaffold A + rMSC (p = 0.035) or 8.75% of scaffold
A+ rMSC (p = 0.002).
Fabrication of Patient-Specific,
CPC-Based Bone Grafts for Alveolar
Cleft Osteoplasty: Proof of Concept
For the application in patients, the fabrication process has
to be scaled up and the shape of the implant has to be
tailored to the patient-individual cleft geometry. In a recent
study, we showed that multichannel 3D plotting of CPC
and a methylcellulose sacrificial ink enables the fabrication
of complex shaped constructs exhibiting anatomical relevant
features including convex and concave curvature at surfaces
(Ahlfeld et al., 2018b). Herein, we successfully transferred
that principle to the full additive manufacturing process chain
from clinical three-dimensional imaging to the fabrication of
a perfectly fitting patient-specific implant (Figure 8). In the
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 8 March 2020 | Volume 8 | Article 217
fbioe-08-00217 March 23, 2020 Time: 20:8 # 9
Korn et al. 3D Printing of Bone Grafts
FIGURE 7 | Histomorphometric analysis. (A) Remaining defect width, (B) bone formation, and (C) percentage of the newly formed bone related to the initial defect
area (n = 8; median and minimum/maximum values; mean is marked by +; *p < 0.05, **p < 0.01, ***p < 0.001). All mean values and standard deviations are shown
in Supplementary Table S1.
first step, anonymized CT data of patients with an alveolar
cleft were reconstructed using the software Dornheim segmenter
achieving a 3D rendered model of the damaged maxilla of the
patient (Figure 8A). The 3D model was then further processed
(i.e., closing holes or smoothing of the polygonal mesh) with
the software tool Geomagic Studio. Finally, the exact defect
area was identified in order to enable the design of a patient-
specific implant. In this case, the modeling of the patient specific
shaped implant was performed utilizing Geomagic Freeform.
This software offers the possibility of haptic interaction. This
enabled us to fit the implant model into the given geometry
of the upper jaw in the best possible way (Figure 8A). The
implant was designed according to the internal and external
geometry of the contralateral orofacial anatomy represented
by the CT data. The dimension of the outer barrier was
chosen to entirely cover the defect’s side edge-to-edge with the
surrounding jaw bone.
The support structure, being required for the production
of real three-dimensional shapes with overhanging structures,
was designed as a negative form of the partially convex
shape of the implant. The resulting 3mf file, capable to
distinguish the two materials (methylcellulose as sacrificial
ink and CPC as biomaterial ink for the implant) was
transferred to the multichannel plotter software being used
for the production of the in vivo scaffolds. Both inks could
be fabricated in layer-wise structure achieving the desired
geometry. The angle between deposited layers was chosen at
60◦ according to the obtained results for ideal tissue integration.
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FIGURE 8 | Design and fabrication process of a patient-specific implant consisting of a calcium phosphate cement. (A) Three-dimensional reconstruction of a CT
scan of a patient and designed model of a perfectly fitting implant. (B) Fabrication process by multichannel 3D plotting of a sacrificial ink and the CPC.
(C) Photograph of the implant, after the sacrificial ink was washed away. (D) The hardened implant fits perfectly into the defect of the patient. Red: Plastic model of
the maxilla with incisors, white: 3D plotted CPC implant.
After hardening of the CPC, the methylcellulose could easily
be dissolved without affecting the implants’ integrity and
geometry (Figures 8B,C). During the mild post-processing of
the CPC (setting in water-saturated atmosphere), no swelling
or shrinking of the plotted scaffolds occurred. This allowed
perfect fitting of the CPC implant into the defect site, as
demonstrated in a partial thermoplastic model of the maxilla,
fabricated based on the reconstructed CT data by fused filament
fabrication (Figure 8D).
DISCUSSION
3D Plotting – Impact of Geometry
The study hypothesis was, that “The application of a 3D
plotted bone graft into an artificial maxillary bone defect
leads to a significant reduction of the defect width after
12 weeks.” This could be confirmed for the scaffold A group.
Crucially, in this experimental group, a significant ongoing
bone formation was measurable, which led to a reduction
of the defect width (significant between 6 and 12 weeks
healing time), confirming that 3D plotting of bone grafts is
a promising approach for application in maxillofacial surgery
and especially for the treatment of alveolar clefts. To evaluate
the defect model itself, an empty defect was compared
and significant bone formation was also shown. However, it
must be stressed, that only the scaffold groups have clinical
relevance for the application in patients, because clinically
there is a strong recommendation for defect augmentation.
Alveolar cleft osteoplasty is performed to build up a sufficient
bone volume into the former cleft area, which is filled by
fibrous tissue and doesn’t enable an eruption of e.g., the
permanent canine. Besides the positive effect on the tooth
eruption the surgery closes oronasal fistulas, which can lead
to oronasal fluid reflux during drinking or eating. If the
alveolar osteoplasty is not performed a disadvantage in maxillary
growing occurs and the deficiency in transversal and anterior-
posterior jaw development causes facial asymmetries and
interferences in dental occlusion. After 12 weeks, scaffold A
led to a significant higher percentage of bone tissue within
the defect area compared to scaffold B. The hypothesis has
to be rebutted for the experimental group of scaffold B, as
the bone formation and reduction of the defect width did
not reach statistical significance after 12 weeks. Thus, it can
be concluded, that the pore geometry of an applied bone
graft has a considerable impact on the treatment of artificial
alveolar clefts.
Extrusion-based additive manufacturing techniques (3D
plotting and fused deposition modeling) allow high control
over the internal pore geometry of scaffolds which was
demonstrated to influence both, mechanical and biological
properties (Hutmacher et al., 2001; Obregon et al., 2015; Kelly
et al., 2018). For example, pore gradients in an osteochondral
tissue model consisting of printed poly-ε-caprolactone scaffolds
showed enhanced osteogenic differentiation of hMSC and
expression of bone markers for a 15◦ layer orientation
compared to 90◦ layer orientation, but enhanced chondrogenic
differentiation of hMSC in the reverse case (Luca et al.,
2016). In addition, Ostrowska et al. (2016) investigated the
differentiation of hMSC on printed PCL scaffolds in vitro
and observed differences in the ALP expression depending
on the layer orientation. Confirming our findings, also in
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this study the layer orientations of 30◦ and 60◦ did not
influence the ALP activity significantly (Ostrowska et al., 2016).
Almeida et al. (2014) compared 3D printed chitosan scaffolds
with 90◦ and 45◦ layer orientation, and thus different pore
geometries, and evidenced an influence of these pores on the
immune response by measuring different levels of TNF-α and
Interleukin 12/23 expression. Likewise, ceramic scaffolds can
be produced by extrusion printing and pore geometry was
demonstrated to play a crucial role on both, mechanics and
bone formation in vivo (Roohani-Esfahani et al., 2016; Entezari
et al., 2019). For plotted CPC constructs, scaffolds with 90◦
(Moussa et al., 2015; Barba et al., 2017; Baranowski et al., 2018;
Reitmaier et al., 2018) and 60◦ (Ahlfeld et al., 2019) lay-down
patterns were investigated in vivo and bone formation could be
evidenced in every study. However, to the best knowledge of
the authors, a comparative study with CPC scaffolds was not
performed so far and the influence of pore geometry is still not
answered satisfactorily.
In our approach, the layer orientation of 60◦ was superior
compared to the layer orientation of 30◦. Crucially, the
layer orientation did not just influence the inner pore
structure, but also the pores at the outer periphery of
the CPC scaffolds (caused by the meanders between
the strands, see Figure 2) which are in direct contact
with the host bone. These outer pores are crucial for
ingrowing bone, which utilizes the scaffold’s surface as
guiding structure, and therefore, their size and shape might
influence this process.
Another aspect of geometry has to be considered for
comprehension of the in vivo results: the contact between scaffold
and osseous defect margin was found to depend on the scaffold
orientation. During surgery, it was easy to place the scaffolds A
or B in the bone defect and clinically the fitting was acceptable
in both groups; no unwanted movement of the scaffold or
gaps occurred. Retrospectively we observed a relevance of the
placement of the bone grafts with the “right site” into the defect:
the scaffolds exhibited a smooth, flattened site due to a layer
deformation which occurred in the first layer due to the contact
with the plotting stage. In layer 2–4, the CPC strands stayed
in round shape and the upper site of the scaffold displayed
convex and concave surfaces. As it did not clinically matter
which site was turned into nasal or oral direction, the position
of the scaffold was randomly chosen. However, analysis of the
micro-CT and histological images revealed that the fitting was
better, showing a minimal distance between bone and scaffold,
if the smooth (bottom) site was placed into oral direction.
In this case, the scaffold represented a guiding structure for
newly formed bone and the closure of a critical size defect
became probable. Thus, both, inner and outer geometry of
the 3D plotted bone scaffolds played a crucial role on the
osseous healing.
Compared to our previous studies conducted in the same
defect model (Korn et al., 2014, 2017), the 3D plotted CPC
scaffolds were superior to granular materials with respect to
fitting into the defect. In both studies, the initial clinical fitting
of the bone grafts, hydroxyapatite-beta-tricalcium phosphate
with a granular structure (BONIT matrix R©) (Korn et al., 2014)
and hydroxyapatite granules embedded in a fast resorbing
collagen matrix (BioOss R© Collagen) (Korn et al., 2017), were
good and there was clinically no distance between defect
margin and scaffold. However, in case of BioOss R© Collagen,
the initial compact structure of the biomaterial was dispersed
into smaller granula and in both studies, fibrous encapsulation
of the particles was observed, probably because of their
instable position within the defect; accordingly, no osseous
integration or complete defect ossification occurred. If the
granulae were located adjacent to the host bone osseous
integration took place leading to the conclusion, that a
more stable, defined structure of the scaffold is required
for further studies. Therefore, plotted CPC scaffolds were
chosen and it can be concluded from the current results that
after 12 weeks the scaffold position was more predictable
compared to the previously tested materials. Although the
problem of dislocation did not occur anymore, there is still
improvement required: a partial degradation of the scaffold is
necessary as the newly formed bone should replace the bone
graft after a defined period of time leading to a complete
defect ossification.
One essential aspect of future research on geometrical issues
could be the realization of anisotropic artificial scaffold structures
as they appear in native bone. Today, this can be achieved
via variation of the strand-to-strand distance and porosity. Our
future aim will be the generation of density gradients in spatial
definition within the fabrication process without the need of
changing the total number of strands by implementing alternative
printing path patterns, which replace the usual printing paths of
straight lines between two points.
Tissue Engineering – Impact of Cell
Pre-colonization
Considering the great potential of the tissue engineering
approach (as alternative to autologous bone graft), we
investigated whether a pre-colonization of the plotted CPC
scaffolds with rMSC enhances bone formation. Compared to
our previous studies, which were conducted with the same
defect model using commercially available and clinically
established materials, the findings presented in the present
study showed distinctly different insights into scaffold-bone
interactions (Korn et al., 2014, 2017). In the first study,
resorbable bone grafts consisting of a synthetic nanocrystalline
hydroxyapatite-beta-tricalcium phosphate mixture (BONIT
matrix R©), which had a granular structure, were colonized
with undifferentiated as well as osteogenically differentiated
rMSC prior to implantation. The smallest defect, and therefore
strongest new bone formation, was observed in the group
using bone grafts with undifferentiated rMSC (remaining defect
width after 6 weeks: 2.39 mm ± 0.23 mm). Compared to the
non-enriched scaffolds, which exposed a remaining defect width
of 2.70 mm after 6 weeks, the pre-colonized scaffold was superior,
but this was not statistically significant (Korn et al., 2014). Also
in combination with a bovine hydroxyapatite granule-collagen
graft (BioOss R© Collagen), the undifferentiated rMSC were
more effective compared to the colonization with osteogenic
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differentiated rMSC. Nevertheless, the non-enriched scaffold
without rMSC pre-colonization finally exposed the significantly
smallest remaining defect width after 12 weeks (Korn et al.,
2017). Based on the previous results, only undifferentiated rMSC
were chosen for this experimental study. It was surprising,
that in the current study both, cells on scaffold A or B, did
not show this positive effect. Considering these diverse and
partly contradictory results of preclinical studies, the impact of
rMSC onto the healing in the alveolar cleft remains unclear.
Also in a clinical trial with 20 patients, Hermund et al. (2012)
observed no significant difference of bone formation in the
maxilla between bone scaffolds with or without cells. Ricci et al.
(2012) demonstrated that in cases of vital bone adjacent to the
defect, it may not require a cell-seeded scaffold for complete
defect ossification. They accentuated the inherent problems with
cell-seeding strategies and recommended in case of bone repair
osteoconductive materials like CPC or ceramics in shape of
highly organized 3D scaffolds, that guide the newly formed bone
across the bone defect also without additional cell colonization
(Ricci et al., 2012). In contrast, cell-seeded bone grafts were
shown to induce better bone formation than cell-free equivalents
in other studies (Eniwumide et al., 2007; Korn et al., 2014).
Although our in vitro characterization clearly demonstrated that
rMSC were able to proliferate and differentiate, no significantly
increased bone formation was observed in vivo. In the light
of these observations and the fact that especially after seeding
of scaffolds with clinically relevant dimensions the cells often
suffer from an insufficient supply after implantation due to
the lack of vascularization (Jaklenec et al., 2012), the classical
tissue engineering approach is questionable. A promising
alternative for further studies might be the concept of in situ
tissue engineering which envisages the recruitment of host stem
and progenitor cells to the defect site by chemoattractive factors
released from the scaffold (Ko et al., 2013).
3D Plotted CPC Scaffolds as Potential
Material for Alveolar Cleft Osteoplasty
Classical fabrication methods of bone grafts are limited in their
clinical application with respect to patient-individual treatment,
however, additive manufacturing seems to be a promising
technique to produce implants for alveolar defects. In contrast
to other bone defects, it is mandatory to use biodegradable
materials for the treatment of alveolar clefts, as the patients are
children in growth and non-degradable materials would possibly
influence local growth. This might be the reason, why, up to
now, only a few materials were tested for the treatment of
such defects and most studies concentrate on secondary bone
grafting (Seifeldin, 2016). These materials include hydroxyapatite
granules (Korn et al., 2014, 2017), bio-ceramics coated with
bovine collagen and dipyridamole (Lopez et al., 2018), tricalcium
phosphates (TCP) (Janssen et al., 2014; Berger et al., 2015),
demineralized bone matrix (Francis et al., 2013), thermoplastic
poly-ε-caprolactone (PCL) (Ahn et al., 2018; Puwanun et al.,
2018) or a β-TCP/PCL composite (Raúl et al., 2019). In a
recent review, Martín-del-Campo et al. (2019) suggested several
biomaterial-based strategies which have high potential for cleft
repair. Herein, we introduced a self-setting CPC for the three-
dimensional fabrication of cleft alveolar osteoplasties offering
several advantages. CPC can be plotted into complex shaped
scaffolds revealing high shape fidelity and accuracy and plotted
structures do not change dimensions while post-processing (Lode
et al., 2014; Ahlfeld et al., 2018b). Plotted CPC scaffolds are
highly biocompatible (Lode et al., 2014; Raymond et al., 2018;
Ahlfeld et al., 2019) and can be biofunctionalized to enhance their
biological performance, for example by growth factor loading
(Akkineni et al., 2015; Ahlfeld et al., 2017, 2019; Baranowski
et al., 2018) or even by integration of CPC into bioprinting
with spatially defined cells (Ahlfeld et al., 2018a). For this first
approach, we utilized pure CPC, which is clinically approved
and answers general questions of this approach. CPC plotting
can be miniaturized achieving filigree structures (Ahlfeld et al.,
2017) as used in the scaffolds of this study. Furthermore, we
could show in this work, that CPC scaffolds can be fabricated in
clinically relevant geometries to fill real alveolar defects. As the
CPC formulation transforms into nanocrystalline, bioresorbable
hydroxyapatite (Heinemann et al., 2013), the scaffolds can be
resorbed by osteoclasts (Bernhardt et al., 2014) and are integrated
into the natural bone remodeling process [lasting about 200 days
until 2 years in the human body (Eriksen, 2010)], which we
consider as advantageous for the healing process. However,
our investigations did not confirm visible resorptions of the
scaffolds, which is related to the general slow degradation of
HA forming cements (Thormann et al., 2013). This might be
overcome by composites consisting of CPC and fast degrading
biomaterials such as mesoporous bioactive glass, which were
shown to enhance the degradation of such constructs distinctly
and even to promote osteogenesis (Schumacher et al., 2017;
Richter et al., 2019) or by a novel oil-based calcium doped
magnesium phosphate cement which demonstrated enhanced
degradation (Ewald et al., 2019).
First clinical studies evaluated the effects of printed bone
grafts on osseous healing in alveolar cleft patients. Ahn et al.
(2018) fabricated cleft osteoplasties consisting of PCL by fused
filament fabrication. In an initial case study with a 10-years-old
patient, the scaffold promoted bone formation; after 6 months
45% of the defect was filled by ingrowing bone (Ahn et al.,
2018). A similar approach utilizing a PCL-β-tricalcium phosphate
composite evidenced the potential of bioresorbable bone grafts
for cleft palates (Raúl et al., 2019). In the light of these results,
the approach investigated in this study utilizing 3D plotted CPC
scaffolds demonstrates very high potential for further research
and clinical application (approximately 20% bone formation after
3 months). Nevertheless, more studies are needed to ascertain
the long-term clinical results of alveolar cleft reconstruction
using tissue engineered and additively manufactured bone grafts
(Wu et al., 2018).
Limitations of the Study
The complexity of a congenital human alveolar cleft or palate
cannot be fully displayed by any pre-clinical model. Therefore,
experimental studies are limited to artificial bone defects in
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different models. An established small animal model is the
rat. This is due to the fact that a cleft-like defect can be
prepared surgically in its maxillary bone (Mehrara et al., 2000;
Mostafa et al., 2014). If cells should be transferred inter-
individually, the selection of an inbreeding breed, like Lewis
rats, avoid immunological problems. Advantage of the chosen
animal model, is the possibility to insert bone grafts intraorally.
However, physiological interactions with the oral microorganism
as well as chewing forces can occur. One disadvantage of
the oral defect in a small animal model is the inability of
a complete wound rest. For this reason, rats were fed a soft
diet to reduce micromovements. In a clinical setting, patients
can be nourished by a nasal gastral tube to enable a proper
initial wound rest. A limitation of this study may be the fact,
that the results after 6 and 12 weeks are not gained for the
same animal by e.g., intravital micro-CT imaging. The reason
was, that the imaging properties of CPC did not enable an
accurate quantification of the bone formation and therefore
ex vivo histology was essential to evaluate the defect healing.
Also the number of specimens per defect was limited due to
the sawing- and grinding method, but average 3.2 samples are
acceptable to quantify bone formation in vivo (Bernhardt et al.,
2012). After identifying a promising bone graft in a small animal
model the evaluation in a larger model would be necessary.
Suitable models are dogs (Zhang et al., 2011), primate (Boyne,
2001), and pigs (Caballero et al., 2015). From a clinical point
of view, the tissue engineered bone grafts should be compared
with autologous bone graft and not only with an empty control
defect. This however is only feasible in large animal models
(Pourebrahim et al., 2013). Assuming application of autologous
bone grafts in the rat model, e.g., from the femur, the fixation
into the defect would be challenging. Reasons are the low height
of the defect (less than 0.5 mm) and the open connection into
the nasal cavity, which would lead to an initial dislocation of
the bone granules.
CONCLUSION
3D plotting of CPC is suitable for the fabrication of scaffolds,
which are fitting exactly in an artificial alveolar defect. We could
show that the fabrication of such scaffolds can also be translated
toward clinical indications and real defect geometries of patients.
The pore geometry influences bone formation significantly; a
60◦ strand rotation leading to triangular-shaped pores performed
significantly better than a 30◦ strand rotation. In this study,
an additional colonization with undifferentiated rMSC did not
result in an increased bone formation. Furthermore, no signs
of scaffold degradation occurred, pointing out the necessity of
further material development like modification of the cement
matrix with porogens or adapting the composition toward more
soluble phases. The creation of a sufficient 3D printed and
tissue-engineered bone graft for alveolar cleft osteoplasty could
preserve patients from donor site morbidity. Further studies will
focus on improving the degradation properties of the 3D plotted
bone grafts by using CPC modifications as well as on the stable
fixation in the defect area which might increase the local bone
formation. With regard to clinical application, the behavior of a
new bone graft should also be tested in alveolar defects of large
animal models.
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FIGURE S1 | Histomorphometric analysis. Closest distance between scaffold and
defect margin. (A) Initial distance at time point of implant placement. (B) Final
distance at the end of the study after 6 or 12 weeks (median and
minimum/maximum values, mean is marked by +, *p < 0.05, **p < 0.01).
TABLE S1 | Measurements in the histomorphological images (mean ± standard
deviation) for the remaining defect width, bone formation and percentage of the
newly formed bone related to the initial defect area after 6 and 12 weeks.
TABLE S2 | Measurements in the histomorphological images (mean ± standard
deviation) for the initial and final distance between bony defect margin and scaffold
margin after 6 and 12 weeks.
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